Finally, we performed immunohistochemistry and immunofluorescence staining on glioblastoma samples from the high‐ and low‐risk score groups, confirming the higher expression of CD99, EGFR and VEGFA in the high‐risk group. This evidence concerns the gene VEGFA and glioblastoma.